Amarin: Waiting For The FDAByEdison•Nov 22, 2012Investment summary: Waiting for the FDAAmarin’s (AMRN) potential blockbuster Vascepa (icosapent ethyl) is ostensibly due to be launched into the large US cardiovascular...